Articles on escitalopram from NPS RADARArticles on escitalopram from NPS RADAR

(ES-sigh-TAL-o-pram)
Title Content Type Date Description
Escitalopram (Lexapro, Esipram) for generalised anxiety disorder and social anxiety disorder (social phobia) Professional publication - NPS RADAR - Review 2008-08-01 00:00:00 Escitalopram is the first selective serotonin re-uptake inhibitor (SSRI) to be PBS listed for these indications. The listing does not cover mild anxiety states for which other forms of treatment are more appropriate. Patients are eligible for escitalopram on the PBS if they fail non-pharmacological therapies and have a GP Mental Health Care Plan, or have been assessed by a psychiatrist.
Escitalopram (Lexapro) for major depressive disorder Professional publication - NPS RADAR - Review 2004-02-01 00:00:00 Reviews use of escitalopram for major depressive disorder, including comparison with citalopram and isomer drug design.

NPS RADAR: independent, evidence-based assessment of new drugs, new PBS listings and the latest research for doctors, pharmacists and other health professionals.

RSS FeedRSS feed

Date published: 2009-10-30 00:00:00

Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.

References to brands should not be taken as an endorsement by NPS.